Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

Early diagnosis of hearing loss is important
2017-09-11

  Description: Magteld small Tags: birth defects, hearing loss, Dr Magteld Smith, Department of Otorhinolaryngology

Dr Magteld Smith, lecturer in the
Department of Otorhinolaryngology
at the University of the Free State (UFS)
Photo: Supplied


One of the most common, misunderstood and neglected birth defects in developing countries is hearing loss, which can most severely impair and have a dramatic impact of the quality of life the of the person with hearing loss. 

This is according to Dr Magteld Smith, lecturer in the Department of Otorhinolaryngology at the University of the Free State (UFS). 

“Hearing loss refers to all the different types and levels of hearing loss, from slight to profound hearing loss,” she said. 

Derived from a number of retrospective studies in South Africa, it was found 17 people a day are born with hearing loss. More than 95% of those children are born to hearing parents. This estimate excludes children and adults who lost their hearing after birth. 

According to Dr Smith, hearing loss strikes at the very essence of being human, because it hinders communication with others. To enable people to communicate with those with hearing loss, the university’s Department of South African Sign Language teaches students sign language. This year, the department enrolled 230 students. A number of these students are from the Faculty of Education. These students could from 2017 for the first time choose sign language as a subject.

“Studies have shown that important language skills are learned before the age of three because hearing and learning language are closely tied together. Brain development of the auditory pathways and language cortex is occurring in young children as they respond to auditory and visual language. In families that are part of deaf culture, these parents automatically sign from day one, so the baby is learning visual (sign) language, and the appropriate brain development is occurring.

Beskrywing: Doof readmore Sleutelwoorde: geboorte-afwykings, gehoorverlies, dr Magteld Smith, Departement Otorinolaringologie

About 230 students are enrolled for the subject, South African 
Sign Language, at the UFS. As an assignment some of the students 
were asked to design posters to create deaf awareness among 
others on campus. From the left are: Poleliso Mpahane, 
Masajin Koalepe, Ntshitsa Mosase, and Zoleka Ncamane. 
Photo: Leonie Bolleurs

“However, if a child has an undiagnosed hearing loss and the parents are unaware, the child will not receive the needed language stimulation — and the hoped-for development won’t take place. It is critical to understand that children with hearing loss have their own talents, different levels of intelligence, socioeconomic circumstances and different abilities, just like hearing children. Therefore, one size does not fit all,” Dr Smith said. 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept